newsfilter
← Latest News
GlobeNewswire·

CinCor Pharma to Present at the 32nd Annual Oppenheimer Healthcare Conference

BOSTON, March 03, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ:CINC) a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases, today